nitroblue tetrazolium has been researched along with alloxan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brömme, HJ; Ebelt, H; Peschke, D; Peschke, E | 1 |
| Govindasamy, S; Panneerselvam, S | 1 |
2 other study(ies) available for nitroblue tetrazolium and alloxan
| Article | Year |
|---|---|
Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin.
Topics: Alloxan; Animals; Antioxidants; Colorimetry; Free Radical Scavengers; Glutathione; Hydrogen Peroxide; Imidazoles; Islets of Langerhans; Luminescent Measurements; Melatonin; Nitroblue Tetrazolium; Oxidants; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Superoxides | 1999 |
Sodium molybdate improves the phagocytic function in alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Antigen-Antibody Complex; Diabetes Mellitus, Experimental; Leukocyte Count; Leukocytes; Male; Molybdenum; Neutrophils; Nitroblue Tetrazolium; Phagocytosis; Rats | 2003 |